IPP Bureau
Pembrolizumab + Trastuzumab and chemotherapy met primary endpoint as first line of treatment for GEJ
By IPP Bureau - June 17, 2023
Based on a subgroup analysis by PD-L1 expression from KEYNOTE-811, Merck is working with the US FDA to update the current indication for KEYTRUDA in HER2-positive gastric or GEJ adenocarcinoma
Health Ministry to prepare National Action Plan on AMR 2.0
By IPP Bureau - June 17, 2023
Convergent action on AMR identified as an important area of intervention
MoS Health addresses TB Health Technologies workshop
By IPP Bureau - June 17, 2023
Urges Innovators to produce quality products that can be deployed at scale
USFDA completes inspection at Dr Reddy's Laboratories' Bollaram API unit
By IPP Bureau - June 17, 2023
The inspection closed with zero observations
Briefs: Natco Pharma and Panacea Biotec
By IPP Bureau - June 16, 2023
Panacea Biotec has announced the launch of its new range of high-quality pediatric food & nutritional products
Bliss GVS Pharma updates on inspection by USFDA
By IPP Bureau - June 16, 2023
The company has now received the Establishment Inspection Report (EIR) indicating closure of the inspection
Ipca Laboratories gets Form 483 for API manufacturing facility at Ratlam
By IPP Bureau - June 16, 2023
The company will submit its comprehensive response on these observations to the US FDA
PrecisionLife announces strategic CNS drug development collaboration with Nanopharmaceutics
By IPP Bureau - June 16, 2023
Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio
SMi discloses £6 million seed funding round, bolsters team with new C-suite hire
By IPP Bureau - June 15, 2023
Investment enables development of revolutionary multi-omic platform using super-resolution imaging technology for earlier disease detection and accelerated discovery of therapeutics
Airnov to showcase HDPE bottle range at upcoming CPHI China
By IPP Bureau - June 15, 2023
The new range of HDPE bottles is compliant with US FDA, EU regulations and Chinese DMF registration for use in dry pharmaceutical applications
Philips' direct-to-angio stroke pathway demonstrates improved patient outcomes
By IPP Bureau - June 15, 2023
Economic analysis of cost of Vall d’Hebron University Hospital Stroke Unit shows direct-to-angio stroke pathway can save more than USD 3,000 per patient
Granules India receives ANDA approval for Levetiracetam Tablets
By IPP Bureau - June 15, 2023
Granules now has a total of 58 ANDA approvals from US FDA
Baghel inaugurates the World Blood Donor Day at RML Hospital
By IPP Bureau - June 15, 2023
The slogan for this year's World Blood Donor Day campaign is 'Give blood, give plasma, share life, share often'
Euroapi plans initiatives to support production of APIs in France and Europe
By IPP Bureau - June 15, 2023
Total investments could reach €70 million, of which approximately 15% in R&D and 85% in capex, that would be deployed from 2026
Zydus receives final approval from the USFDA for Diclofenac Sodium and Misoprostol Delayed Release Tablets
By IPP Bureau - June 14, 2023
Diclofenac Sodium and Misoprostol Delayed Release Tablets USP, 50mg/200 mcg and 75mg/200 mcg had annual sales of USD 13 mn in the United States
